Why Ro Is Turning To Walmart For Its Next Phase Of Growth

Media Thumbnail
00:00
00:00
1x
  • 0.5
  • 1
  • 1.25
  • 1.5
  • 1.75
  • 2
This is a podcast episode titled, Why Ro Is Turning To Walmart For Its Next Phase Of Growth. The summary for this episode is: <p>Started in 2017, Ro is a health care technology company building a patient-centric healthcare system. The pandemic gave rise to a remarkable time of growth for the company, marked by the rise of telehealth and multiple acquisitions by the business. Since just this spring, Ro has launched a one of kind in-home vaccination program, <a href="https://www.forbes.com/sites/katiejennings/2021/03/22/digital-health-startup-ro-raised-500-million-at-5-billion-valuation/?sh=5e5eac5462f5" rel="noopener noreferrer" target="_blank" class="keychainify-checked">raised $500M in funding</a>, acquired two companies (Modern Fertility and diagnostics startup Kit), and premiered its products across 97% of Walmart stores in the US. I sat down with Rob Schutz, Chief Growth Officer and Co- Founder of Ro, to talk about the company’s growth trajectory, the boom of telehealth during COVID, and their new national rollout with Walmart.</p>

DESCRIPTION

Started in 2017, Ro is a health care technology company building a patient-centric healthcare system. The pandemic gave rise to a remarkable time of growth for the company, marked by the rise of telehealth and multiple acquisitions by the business. Since just this spring, Ro has launched a one of kind in-home vaccination program, raised $500M in funding, acquired two companies (Modern Fertility and diagnostics startup Kit), and premiered its products across 97% of Walmart stores in the US. I sat down with Rob Schutz, Chief Growth Officer and Co- Founder of Ro, to talk about the company’s growth trajectory, the boom of telehealth during COVID, and their new national rollout with Walmart.